Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Use of calreticulin and calreticulin fragments to inhibit endothelial cell growth and angiogenesis, and suppress tumor growth

Use of calreticulin and calreticulin fragments to inhibit endothelial cell growth and angiogenesis, and suppress tumor growth

US Patent 7488711 · Granted Feb 10, 2009

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Receptor tyrosine kinase inhibitors for treatment of protein kinase modulation-r2025
Methods of preparing a re-usable single cell and methods for analyzing the epige2022
Induced internalization of surface receptors2013
Vasostatin as marrow protectant2010
Vasostatin as marrow protectant2010
Vasostatin as marrow protectant2010
Vasostatin as marrow protectant2008
Vasostatin as marrow protectant2008
Vasostatin as marrow protectant2008
Specific binding agents for KSHV vIL-6 that neutralize a biological activity2008
Specific binding agents for KSHV vIL-6 that neutralize a biological activity2007
Specific binding agents for KSHV vIL-6 that neutralize a biological activity2006